The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
With news that the country has now vaccinated half of its population with at least one dose, This Drew Altman Axios column highlights the persistent COVID-19 vaccine myths that are believed by a substantial portion of the unvaccinated population and discusses the options to address vaccine misinformation.
Providing paid time off to employees to get and recover from any side effects could help boost vaccination rates. Overall, nearly three in ten (28%) employed adults who not yet ready to get the vaccine say that they would be more likely to get the COVID-19 vaccine if their employer gave them paid time off to get vaccinated and recover from any side effects.
The Survey on Race and Health is a joint project between KFF and ESPN’s The Undefeated exploring the public’s views and experiences on health care, racial discrimination, and the coronavirus pandemic. It includes a special focus on the views and experiences of Black Americans, including unconscious bias and structural racism; experiences and trust in the health care system; the social and economic impacts of the pandemic; and views of a potential COVID-19 vaccine.
This issue brief examines key issues related to multi-dose vaccination series generally as well as issues specific to COVID-19.
Updated analysis of state-reported data as of February 1, 2021 on COVID-19 vaccinations, cases, and deaths by race/ethnicity is now available.
Additional Data Available Through Online Vaccine Monitor Dashboard As vaccination efforts ramp up across the country, the KFF COVID-19 Vaccine Monitor examines where the public is getting its relevant information.
During the 53rd week since the first coronavirus case appeared in the United States, the world surpassed 100 million COVID-19 cases, with the United States accounting for a quarter of them. The U.S. also accounts for one-fifth (433,200) of the world’s nearly 2.2 million reported deaths.
Debate about how many vaccinations are needed by when has been in the news. Drew Altman lays it out in his latest column.
This brief reviews why racial diversity within COVID-19 vaccine clinical trials is important, discusses the barriers to participation in clinical trials among people of color, and examines the racial/ethnic composition of clinical trial participants for the Pfizer-BioNTech and Moderna vaccines.
Across states, data to understand access to and uptake of the vaccine by race/ethnicity and other demographic factors will be central to efforts to ensure equity. KFF is compiling and will regularly update state-reported data on vaccination by race/ethnicity through its COVID-19 state data and policy tracker.
© 2025 KFF